| 今开：19.61 | 昨收：19.83 |
| 最高：20.66 | 最低：19.08 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5.31782419E8 |
医药魔方2023-10-11 12:09
10月9日，AnaptysBio宣布imsidolimab（ANB019）治疗泛发性脓疱型银屑病（GPP）的全球性III期GEMINI-1研究取得了积极的关键结果。
点击下载：银屑病治疗中创新药的竞争格局分析
该研究是一项为期4周的随机、...查看全文
产业链观察2023-10-10 02:50
#药闻简讯# 2023年10月9日--$AnaptysBio(ANAB)$ 公司周一表示，其治疗一种罕见皮肤病的实验性药物在一项后期研究中达到了主要目标。
这种药物有助于在四周内清除泛发性脓疱型银屑病患者身上的脓疱。
该药物开发商计划在 2024 年第三季度之前向美国食品药品管理局提交该药物（伊西多利单抗...查看全文
AnaptysBio(ANAB)03-27 08:15
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009164 Size: 8 KB 网页链接查看全文
AnaptysBio(ANAB)03-12 04:45
$AnaptysBio(ANAB)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001370053-24-000012 Act: 33 Size: 138 KB 网页链接查看全文
AnaptysBio(ANAB)03-12 04:45
$AnaptysBio(ANAB)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001370053-24-000011 Act: 34 Size: 27 MB 网页链接查看全文
AnaptysBio(ANAB)03-12 04:25
$AnaptysBio(ANAB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001370053-24-000010 Act: 34 Size: 308 KB 网页链接查看全文
AnaptysBio(ANAB)02-17 06:25
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001087 Act: 33 Size: 6 KB 网页链接查看全文
AnaptysBio(ANAB)02-22 06:45
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004666 Size: 9 KB 网页链接查看全文
AnaptysBio(ANAB)02-15 05:05
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002860 Act: 34 Size: 87 KB 网页链接查看全文
AnaptysBio(ANAB)02-14 21:45
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-000909 Act: 34 Size: 103 KB 网页链接查看全文
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-009164 Size: 8 KB 网页链接
$AnaptysBio(ANAB)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001370053-24-000011 Act: 34 Size: 27 MB 网页链接
$AnaptysBio(ANAB)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001370053-24-000012 Act: 33 Size: 138 KB 网页链接
$AnaptysBio(ANAB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001370053-24-000010 Act: 34 Size: 308 KB 网页链接
$AnaptysBio(ANAB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-004666 Size: 9 KB 网页链接
$AnaptysBio(ANAB)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001087 Act: 33 Size: 6 KB 网页链接
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-24-002860 Act: 34 Size: 87 KB 网页链接
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-24-001629 Act: 34 Size: 60 KB 网页链接
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-000909 Act: 34 Size: 103 KB 网页链接
$AnaptysBio(ANAB)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020284 Act: 34 Size: 13 KB 网页链接